Kidney Research UK, the leading charity dedicated to kidney health, has made a significant investment in Healthinote, the patient engagement platform from Cognitant Group Ltd, a provider of digital education and support tools that improve the management of long-term conditions.

英国肾脏研究领域领先的慈善机构 Kidney Research UK 对 Cognitant Group Ltd 旗下的患者参与平台 Healthinote 进行了重大投资，该公司提供改善长期病症管理的数字教育和支持工具。

This strategic move by Kidney Research UK is a recognition of the powerful impact that innovative, patient-centred digital resources can have on improving health outcomes for individuals living with kidney disease and related conditions.

英国肾脏研究的战略举措表明，创新的、以患者为中心的数字资源可以对改善肾病及相关疾病患者的健康结果产生强大的影响。

The charity’s decision to invest follows the proven success of Cognitant’s Kidney Essentials programme, co-created by Cognitant and the Royal Berkshire NHS Foundation Trust.  It has demonstrated substantial positive outcomes in the management of kidney disease.

该慈善机构决定投资，这是基于Cognitant与伯克郡皇家NHS基金会信托共同创建的Cognitant肾病精华项目已被证明的成功。该项目在肾病管理方面展现了显著的积极成果。

Katherine Forbes, Director of Innovation and Enterprise at Kidney Research UK, said: “Healthinote gives patients free access to evidence-based resources, tailored to their needs, that helps to personalise their care. Through this digital, multi-language programme, patients will be better informed and empowered in their self-care and management of their condition, improving their quality of life and saving patients’ and clinicians’ time.”.

英国肾脏研究创新与企业总监凯瑟琳·福布斯表示：“Healthinote为患者提供免费的、基于证据的资源，根据他们的需求量身定制，有助于个性化护理。通过这个数字化、多语言的项目，患者将能够更好地获取信息，在自我护理和病情管理中得到赋能，从而提升生活质量，同时节省患者和临床医生的时间。”

Kidney Essentials has been shown to significantly improve patient understanding of their condition, and as an important element of a hybrid care model, reduce waiting times and necessary face to face consultations – a key issue identified in Lord Dazi’s report on the NHS last year. The aim is to ensure patients receive continuous and holistic support through every stage of their healthcare journey, prescribed by clinicians and integrated with NHS services..

肾病 essentials 已被证明能够显著提高患者对其病情的理解，并作为混合护理模式的重要组成部分，减少等待时间和必要的面对面会诊——这是达齐勋爵去年在 NHS 报告中指出的关键问题。目标是确保患者在医疗保健过程的每个阶段都能获得持续且全面的支持，由临床医生开具处方并整合到 NHS 服务中。

Kidney disease disproportionately affects certain communities, particularly those from Black and South Asian backgrounds, who are at higher risk of developing kidney-related conditions. Kidney Research UK’s investment will address health inequalities in line with NHS England’s Core20PLUS5 approach, by ensuring that patients from all backgrounds have access to high-quality, culturally relevant information..

肾脏疾病对某些群体的影响尤为严重，特别是那些来自黑人和南亚背景的人群，他们患肾脏相关疾病的风险更高。英国肾脏研究基金会的投资将遵循英格兰国家医疗服务体系（NHS England）的Core20PLUS5方法，解决健康不平等问题，确保所有背景的患者都能获得高质量且文化相关的资讯。

The initiative also closely aligns with the NHS Rightcare cardiovascular disease prevention care pathway, aiming to reduce the estimated 1.2 million people who have undiagnosed chronic kidney disease.

该倡议还与NHS Rightcare心血管疾病预防护理路径紧密契合，旨在减少大约120万未诊断慢性肾病的人数。

Dr. Tim Ringrose, CEO of Cognitant, commented: “Kidney Research UK recognise the tremendous potential of digital services to improve patient care. Kidney Essentials has already made a meaningful difference in the lives of patients managing kidney disease, while saving time and improving efficiency for the NHS..

Cognitant首席执行官蒂姆·林 grove博士评论道：“英国肾脏研究协会认识到数字服务在改善患者护理方面的巨大潜力。肾脏精华已经在管理肾病的患者生活中产生了有意义的改变，同时也为NHS节省了时间并提高了效率。”

The partnership reflects our shared commitment to improving equitable health outcomes for patients with cardio-renal-metabolic conditions.”

该合作伙伴关系反映了我们对改善心脏-肾脏-代谢疾病患者的健康结果的共同承诺。